Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: Is there a relationship?

International Archives of Allergy and Immunology

Volumn 158, Issue 3, 2012, Pages 276-280

  Asero, R ^a   Farioli, L ^b   Pastorello, E A ^b  

^a Ospedale 21   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Immunotherapy; Mast cells; Respiratory allergy; Tryptase

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; TRYPTASE;

ADULT; AGED; ARTICLE; ATOPY; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IMMUNOTHERAPY; INJECTION SPECIFIC IMMUNOTHERAPY; MALE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY;

ADOLESCENT; ADULT; AGED; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLLEN; RESPIRATORY HYPERSENSITIVITY; RISK FACTORS; TRYPTASES; YOUNG ADULT;

EID: 84857728932     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000331315     Document Type: Article

References (13)

1. González de Olano D, de la Hoz Caballer B, Núñez López R, Sánchez Muñoz L, Cuevas Agustín M, Diéguez MC, Alvarez Twose I, Castells MC, Escribano Mora L: Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007; 37: 1547-1555. (Pubitemid 47460231)
2. Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-232.
3. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, Martinelli G, Chilosi M, Senna G, Pizzolo G, Zanotti R: Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123: 680-686.
4. Bonadonna P, Zanotti R, Müller U: Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol 2010; 10: 347-353.
5. Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta- Lukaszyk A, Bonifazi F, Bucher C, Campi P, Darsow U, Egger C, Haeberli G, Hawranek T, Kucharewicz I, Küchenhoff H, Lang R, Quercia O, Reider N, Severino M, Sticherling M, Sturm GJ, Wüthrich B; European Academy of Allergy and Clinical Immunology Interest Group: Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol 2010; 126: 105-111.
6. Bonadonna P, Zanotti R, Pagani M, Caruso B, Perbellini O, Colarossi S, Olivieri E, Dama A, Schiappoli M, Senna G, Antico A, Passalacqua G: How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy 2009; 64: 1379-1382.
7. Frew AJ: Allergen immunotherapy J Allergy Clin Immunol 2010; 125(suppl):S306-S313.
8. Schiappoli M, Ridolo E, Senna G, Alesina R, Antonicelli L, Asero R, Costantino MT, Longo R, Musarra A, Nettis E, Crivellaro M, Savi E, Massolo A, Passalacqua G: A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp Allergy 2009; 39: 1569-1574.
9. Malling HJ, Weeke B: Position paper: immunotherapy. Allergy 1993; 48(suppl 14):9-35. (Pubitemid 23222930)
10. Bousquet J, Lockey RF, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. Allergy 1998; 53(suppl 44):1-42. (Pubitemid 28346358)
11. Alvarez-Twose I, González de Olano D, Sánchez- Muñoz L, Matito A, Esteban-López MI, vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L: Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 2010; 125: 1269-1278.
12. Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta- Lukaszyk A, Bonifazi F, Bucher C, Campi P, Darsow U, Egger C, Haeberli G, Hawranek T, Körner M, Kucharewicz I, Küchenhoff H, Lang R, Quercia O, Reider N, Severino M, Sticherling M, Sturm GJ, Wüthrich B: Predictors of severe anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline tryptase - a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect venom Hypersensititvity. J Allergy Clin Immunol 2009; 124: 1047-1054.
13. Akim C, valent P, Metcalfe DD: Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol 2010; 126: 1099-1104.